Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 33, 2018 - Issue 1
Research Paper
Diaryl ethers with carboxymethoxyphenacyl motif as potent HIV-1 reverse transcriptase inhibitors with improved solubility
Tomasz FrączekInstitute of Applied Radiation Chemistry, Lodz University of Technology, Lodz, Poland; 
http://orcid.org/0000-0002-2496-9508View further author information
http://orcid.org/0000-0002-2496-9508View further author information, , Agnieszka KrakowiakInstitute of Applied Radiation Chemistry, Lodz University of Technology, Lodz, Poland; ;Department of Bioorganic Chemistry, Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Lodz, Poland; http://orcid.org/0000-0002-0273-2972View further author information
http://orcid.org/0000-0002-0273-2972View further author information, , Bruno VerhasseltDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent University Hospital, Ghent, BelgiumCorrespondence[email protected]
http://orcid.org/0000-0002-4645-1144View further author information
http://orcid.org/0000-0002-4645-1144View further author information & Piotr PanethInstitute of Applied Radiation Chemistry, Lodz University of Technology, Lodz, Poland; Correspondence[email protected]
http://orcid.org/0000-0002-3091-8387View further author information
http://orcid.org/0000-0002-3091-8387View further author informationRelated Research Data
Estimation and correlation of drug water solubility with pharmacological parameters required for biological activity
Source:
Elsevier BV
The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection
Source:
Elsevier BV
New Solid Forms of the Anti-HIV Drug Etravirine: Salts, Cocrystals, and Solubility
Source:
American Chemical Society (ACS)
Extremely High Mutation Rate of HIV-1 In Vivo.
Source:
Public Library of Science (PLoS)
Positive Effects of Combined Antiretroviral Therapy on CD4+ T Cell Homeostasis and Function in Advanced HIV Disease
Source:
American Association for the Advancement of Science (AAAS)
Computationally-guided optimization of a docking hit to yield catechol diethers as potent anti-HIV agents.
Source:
American Chemical Society (ACS)
Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes
Source:
American Chemical Society (ACS)
Preparation of α-Bromoketones and Thiazoles from Ketones with NBS and Thioamides in Ionic Liquids
Source:
Scientific Research Publishing, Inc.
Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses.
Source:
Elsevier BV
Genome-wide shRNA screening identifies host factors involved in early endocytic events for HIV-1-induced CD4 down-regulation
Source:
Springer Science and Business Media LLC
The accuracy of reverse transcriptase from HIV-1.
Source:
American Association for the Advancement of Science (AAAS)
HIV Triggers a cGAS-Dependent, Vpu- and Vpr-Regulated Type I Interferon Response in CD4+ T Cells.
Source:
The Author(s).
A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors.
Source:
Ovid Technologies (Wolters Kluwer Health)
Structural and biochemical effects of human immunodeficiency virus mutants resistant to non-nucleoside reverse transcriptase inhibitors.
Source:
Elsevier BV
Recent Advances in the Design and Development of Non-nucleoside Reverse Transcriptase Inhibitor Scaffolds.
Source:
Wiley
New N- and O-arylations with phenylboronic acids and cupric acetate
Source:
Elsevier BV
Assessing Molecular Docking Tools for Relative Biological Activity Prediction: A Case Study of Triazole HIV-1 NNRTIs
Source:
American Chemical Society (ACS)
Miniperspective
Source:
American Chemical Society (ACS)
Extension into the entrance channel of HIV-1 reverse transcriptase--crystallography and enhanced solubility.
Source:
Elsevier BV
Optimization of Diarylazines as Anti-HIV Agents with Dramatically Enhanced Solubility
Source:
Elsevier BV
The Current Status of the NNRTI Family of Antiretrovirals Used Against HIV Infection
Source:
Bentham Science Publishers Ltd.
2008 Recommendations of the International AIDS Society–USA Panel
Source:
American Medical Association (AMA)
HIV-1 NNRTIs
Source:
Wiley
Phase 2a randomized controlled trial of short-term activity, safety, and pharmacokinetics of a novel nonnucleoside reverse transcriptase inhibitor, RDEA806, in HIV-1-positive, antiretroviral-naive subjects.
Source:
American Society for Microbiology
Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant viruses.
Source:
American Chemical Society (ACS)
Linking provided by
